# Safety Profile of a New Berberine Formulation with Improved Bioavailability

> **NCT06732908** · NA · COMPLETED · sponsor: **Isura** · enrollment: 19 (actual)

## Conditions studied

- Safety

## Interventions

- **DIETARY_SUPPLEMENT:** LipoMicel Berberine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06732908
- **Lead sponsor:** Isura
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-27
- **Primary completion:** 2024-08-27
- **Final completion:** 2024-10-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06732908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06732908, "Safety Profile of a New Berberine Formulation with Improved Bioavailability". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06732908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*